IP Library › Assignment 049919/0884
Patent Assignment
Reel/Frame 049919/0884

Change of Name

Recorded: 2019-07-31 Pages: 8
Assignor
AERPIO THERAPEUTICS, INC.
Executed: 2017-03-15
Assignee
AERPIO THERAPEUTICS LLC
9987 CARVER ROAD, CINCINNATI, OHIO, 45242
Covered Properties (7)
Methods for Treating Vascular Leak Syndrome
Application: 12/677,512 →
Publication: US 2011/0268694
Methods for Treating Vascular Leak Syndrome
Patent: 9,096,555 →
Application: 13/724,396 →
Publication: US 2014/0179693
Methods for Treating Vascular Leak Syndrome
Application: 13/968,269 →
Publication: US 2013/0331386
Methods for Treating Vascular Leak Syndrome
Application: 14/075,809 →
Publication: US 2014/0066458
Methods for Treating Vascular Leak Syndrome
Application: 15/443,353 →
Publication: US 2018/0016245
Methods for Treating Vascular Leak Syndrome
Application: 61/144,022 →
Methods for Reducing Vascular Leakage Induced by Pathogens
Application: 61/184,986 →
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 25, 2013
From: SHALWITZ, ROBERT; PETERS, KEVIN GENE
To: AERPIO THERAPEUTICS INC.
Reel/Frame 030680/0206 →
Assignment of Assignor's Interest Feb 13, 2015
From: SHALWITZ, ROBERT; PETERS, KEVIN GENE
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 034957/0602 →
Assignment of Assignor's Interest Mar 4, 2015
From: SHALWITZ, ROBERT; PETERS, KEVIN GENE
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 035083/0090 →
Assignment of Assignor's Interest Mar 31, 2017
From: SHALWITZ, ROBERT; PETERS, KEVIN GENE
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 041804/0685 →
Corrective Assignment to Correct the Receiving Party Address Previously Recorded at Reel: 030680 Frame: 0206. Assignor(S) Hereby Confirms the Assignment. Apr 10, 2019
From: SHALWITZ, ROBERT; PETERS, KEVIN
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 048853/0091 →
Assignment of Assignor's Interest Apr 17, 2020
From: AERPIO THERAPEUTICS LLC
To: AERPIO PHARMACEUTICALS, INC.
Reel/Frame 052432/0789 →
Assignment of Assignor's Interest Sep 9, 2021
From: AERPIO PHARMACEUTICALS, INC.
To: EYEPOINT PHARMACEUTICALS, INC.
Reel/Frame 057448/0033 →